Recent Funding
Companies
Oyster Therapeutics

Oyster Therapeutics

Oyster Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.

Latest funding

$60M Series A · November 10, 2026

Led by 4BIO Capital · Source: finance.yahoo.com

Funding history ↓

Website: oyster-tx.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Life Science, Medical.

Stage: Series A.

Based in: London, United Kingdom.

Last round: Nov 10, 2026 · 2 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 11, 2026.

Signals

Website registeredOct 13, 2026 (1 month old)

Funding rounds

November 10, 2026
Series A · $60M
44BIO Capital (lead), AActium Group, CCE Ventures (CEIIF), EEli Lilly, GGlobal Brain Corporation, MMass General Brigham Ventures, MMission BioCapital, OOxford Science Enterprises, SSyncona Partners LLP
Source: finance.yahoo.com
October 13, 2026
Website created

Team

CD
Clive Dix Chairman

Investors

Companies like Oyster Therapeutics

LLaekna Therapeutics$61M Series B+ · May 2022
TTRIMTECH Therapeutics$14M Seed · Jun 2026
OOMass Therapeutics$310M Series B+ · Oct 2026
OOberland BiotechSeed · May 2026
EEntelo Bio$4M Seed · Apr 2026
AAtavistik Bio$40M Series B+ · Mar 2026

Other companies backed by 4BIO Capital

EEstuary Biotherapeutics$103M Series A · Oct 2026
UUndecimal Bio$18M Seed · Oct 2026
AAptadir Therapeutics$45M Seed · Sep 2026
CCloverleaf Bio$33M Seed · Sep 2026
AActithera$75.5M Series A · Jul 2025

4BIO Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oyster-therapeutics (get a free API key).